184 related articles for article (PubMed ID: 18491139)
1. In vitro and in vivo antileishmanial activities of a Brazilian green propolis extract.
Pontin K; Da Silva Filho AA; Santos FF; Silva ML; Cunha WR; Nanayakkara NP; Bastos JK; de Albuquerque S
Parasitol Res; 2008 Aug; 103(3):487-92. PubMed ID: 18491139
[TBL] [Abstract][Full Text] [Related]
2. In vitro sensitivity of Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis Brazilian isolates to meglumine antimoniate and amphotericin B.
Zauli-Nascimento RC; Miguel DC; Yokoyama-Yasunaka JK; Pereira LI; Pelli de Oliveira MA; Ribeiro-Dias F; Dorta ML; Uliana SR
Trop Med Int Health; 2010 Jan; 15(1):68-76. PubMed ID: 19874570
[TBL] [Abstract][Full Text] [Related]
3. Brazilian brown propolis elicits antileishmanial effect against promastigote and amastigote forms of Leishmania amazonensis.
Santana LC; Carneiro SM; Caland-Neto LB; Arcanjo DD; Moita-Neto JM; Citó AM; Carvalho FA
Nat Prod Res; 2014; 28(5):340-3. PubMed ID: 24261482
[TBL] [Abstract][Full Text] [Related]
4. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA
Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species.
Nieto-Meneses R; Castillo R; Hernández-Campos A; Maldonado-Rangel A; Matius-Ruiz JB; Trejo-Soto PJ; Nogueda-Torres B; Dea-Ayuela MA; Bolás-Fernández F; Méndez-Cuesta C; Yépez-Mulia L
Exp Parasitol; 2018 Jan; 184():82-89. PubMed ID: 29191699
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Thymus vulgaris (Thyme), Achillea millefolium (Yarrow) and propolis hydroalcoholic extracts versus systemic glucantime in the treatment of cutaneous leishmaniasis in balb/c mice.
Nilforoushzadeh MA; Shirani-Bidabadi L; Zolfaghari-Baghbaderani A; Saberi S; Siadat AH; Mahmoudi M
J Vector Borne Dis; 2008 Dec; 45(4):301-6. PubMed ID: 19248657
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen as a potential antileishmanial agent: efficacy in the treatment of Leishmania braziliensis and Leishmania chagasi infections.
Miguel DC; Zauli-Nascimento RC; Yokoyama-Yasunaka JK; Katz S; Barbiéri CL; Uliana SR
J Antimicrob Chemother; 2009 Feb; 63(2):365-8. PubMed ID: 19095684
[TBL] [Abstract][Full Text] [Related]
8. Antileishmanial activity of a tetralone isolated from Ampelocera edentula, a Bolivian plant used as a treatment for cutaneous leishmaniasis.
Fournet A; Barrios AA; Muñoz V; Hocquemiller R; Roblot F; Cavé A
Planta Med; 1994 Feb; 60(1):8-12. PubMed ID: 8134421
[TBL] [Abstract][Full Text] [Related]
9. Intraspecies susceptibility of Leishmania (Viannia) braziliensis to antileishmanial drugs: Antimony resistance in human isolates from atypical lesions.
Rugani JN; Quaresma PF; Gontijo CF; Soares RP; Monte-Neto RL
Biomed Pharmacother; 2018 Dec; 108():1170-1180. PubMed ID: 30372818
[TBL] [Abstract][Full Text] [Related]
10. Antileishmanial activity of azithromycin against Leishmania (Leishmania) amazonensis, Leishmania (Viannia) braziliensis, and Leishmania (Leishmania) chagasi.
de Oliveira-Silva F; de Morais-Teixeira E; Rabello A
Am J Trop Med Hyg; 2008 May; 78(5):745-9. PubMed ID: 18458308
[TBL] [Abstract][Full Text] [Related]
11. Poloxamer 407 (Pluronic(®) F127)-based polymeric micelles for amphotericin B: In vitro biological activity, toxicity and in vivo therapeutic efficacy against murine tegumentary leishmaniasis.
Mendonça DV; Lage LM; Lage DP; Chávez-Fumagalli MA; Ludolf F; Roatt BM; Menezes-Souza D; Faraco AA; Castilho RO; Tavares CA; Barichello JM; Duarte MC; Coelho EA
Exp Parasitol; 2016 Oct; 169():34-42. PubMed ID: 27427166
[TBL] [Abstract][Full Text] [Related]
12. In vitro leishmanicidal activity of imidazole- or pyrazole-based benzo[g]phthalazine derivatives against Leishmania infantum and Leishmania braziliensis species.
Sánchez-Moreno M; Gómez-Contreras F; Navarro P; Marín C; Ramírez-Macías I; Olmo F; Sanz AM; Campayo L; Cano C; Yunta MJ
J Antimicrob Chemother; 2012 Feb; 67(2):387-97. PubMed ID: 22127582
[TBL] [Abstract][Full Text] [Related]
13. The antifungal compound butenafine eliminates promastigote and amastigote forms of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis.
Bezerra-Souza A; Yamamoto ES; Laurenti MD; Ribeiro SP; Passero LF
Parasitol Int; 2016 Dec; 65(6 Pt A):702-707. PubMed ID: 27546158
[TBL] [Abstract][Full Text] [Related]
14. Effect of thiadiazine derivatives on intracellular amastigotes of Leishmania amazonensis.
Monzote Fidalgo L; Montalvo Alvarez AM; Geigel LF; Pérez Pineiro R; Suárez Navarro M; Rodríguez Cabrera H
Mem Inst Oswaldo Cruz; 2004 May; 99(3):329-30. PubMed ID: 15273809
[TBL] [Abstract][Full Text] [Related]
15. A Luciferase-Expressing Leishmania braziliensis Line That Leads to Sustained Skin Lesions in BALB/c Mice and Allows Monitoring of Miltefosine Treatment Outcome.
Coelho AC; Oliveira JC; Espada CR; Reimão JQ; Trinconi CT; Uliana SR
PLoS Negl Trop Dis; 2016 May; 10(5):e0004660. PubMed ID: 27144739
[TBL] [Abstract][Full Text] [Related]
16. American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis resistant to meglumine antimoniate, but with good response to pentamidine: a case report.
Pimentel MI; Baptista C; Rubin EF; Vasconcellos Ede C; Lyra MR; Salgueiro Mde M; Saheki MN; Rosalino CM; Madeira Mde F; Silva AF; Confort EM; Schubach Ade O
Rev Soc Bras Med Trop; 2011; 44(2):254-6. PubMed ID: 21552747
[TBL] [Abstract][Full Text] [Related]
17. Antileishmanial, antioxidant, and cytotoxic activities of Quercus infectoria Olivier extract.
Kheirandish F; Delfan B; Mahmoudvand H; Moradi N; Ezatpour B; Ebrahimzadeh F; Rashidipour M
Biomed Pharmacother; 2016 Aug; 82():208-15. PubMed ID: 27470357
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo leishmanicidal activity of Astronium fraxinifolium (Schott) and Plectranthus amboinicus (Lour.) Spreng against Leishmania (Viannia) braziliensis.
de Lima SC; Teixeira MJ; Lopes JE; de Morais SM; Torres AF; Braga MA; Rodrigues RO; Santiago GM; Martins AC; Nagao-Dias AT
Biomed Res Int; 2014; 2014():848293. PubMed ID: 24829921
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR
Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
[TBL] [Abstract][Full Text] [Related]
20. Responses of Leishmania (Viannia) braziliensis cutaneous infection to N-methylglucamine antimoniate in the rhesus monkey (Macaca mulatta) model.
Teva A; Porrozzi R; Oliveira-Neto MP; Grimaldi GJ
J Parasitol; 2005 Aug; 91(4):976-8. PubMed ID: 17089782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]